Ivermectin for Covid

[Cook&Bro]

The NIH have revised their guidance on the use of Ivermectin in the treatment of Covid.

The current landing page on the NIH website on this subject:

https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/ivermectin/

States that;

• The COVID-19 Treatment Guidelines Panel recommends against the use of ivermectin for the treatment of COVID-19, except in a clinical trial (AIII).

However, the information header on the page takes you to the revised guidance;

https://www.covid19treatmentguidelines.nih.gov/statement-on-ivermectin/ which states;

• The COVID-19 Treatment Guidelines Panel (the Panel) has determined that currently there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19. Results from adequately powered, well-designed, and well-conducted clinical trials are needed to provide more specific, evidence-based guidance on the role of ivermectin for the treatment of COVID-19.

This is actually a good thing as explained in the following link;

Per that video, the "insufficient data" status is the same as that for monoclonal antibodies and convalescent plasma.

With this revision by NIH, it may be easier to obtain prescriptions from PCPs.